The strongest version of this narrative highlights how industry consolidation creates cascading opportunities for smaller players, driven by regulatory mandates and strategic realignment. The agrochemical sector’s cyclical M&A activity—peaking during downturns—reflects a broader pattern of corporate streamlining, where divestitures of "non-core" or low-margin assets become leverage for mid-tier firms. The article credibly maps these transactions, showing how antitrust enforcement (e.g., Bayer’s ...